NCT05025397View on ClinicalTrials.gov

A Study of Danavorexton in Anesthetized Adults

PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

September 28, 2021

Primary Completion Date

March 8, 2022

Study Completion Date

March 8, 2022

Conditions
Healthy Volunteers
Interventions
DRUG

Danavorexton

Danavorexton intravenous infusion.

DRUG

Danavorexton Placebo

Danavorexton placebo-matching intravenous infusion.

DRUG

Propofol

Propofol intravenous bolus.

DRUG

Sevoflurane

Sevoflurane inhalation.

DRUG

Propofol

Propofol intravenous infusion.

Trial Locations (1)

78229-3818

Endeavor Clinical Trials, San Antonio

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY